More Evidence Gene Therapy Might Cure Sickle Cell Disease
MONDAY, June 12, 2023 (HealthDay News) — A clinical trial that’s attempting to discover a cure for sickle cell disease has found a new gene therapy to be safe and successful in four patients.Two of the patients were treated at Cleveland Clinic Childr…
Learn MoreUn anticonceptivo inyectado podría ser revolucionario para el control de las poblaciones de gatos callejeros
MARTES, 6 de junio de 2023 (HealthDay News) — Por todo el mundo deambulan millones de gatos callejeros, y hace mucho que la esterilización quirúrgica ha sido el principal método de control de la población. Pero un nuevo estudio de tamaño reducido mue…
Learn MoreInjected Birth Control Could Be Game-Changer to Curb Stray Cat Populations
TUESDAY, June 6, 2023 (HealthDay News) — Millions of stray cats roam the world over, and surgical sterilization has long been the primary method of population control.But a small new study shows promising results for a one-and-done contraceptive inje…
Learn MoreGene Therapy Not Cost-Effective for Sickle Cell by Conventional Measures
MONDAY, June 5, 2023 (HealthDay News) — For persons with sickle cell disease (SCD), gene therapy seems not to be cost-effective per conventional cost-effectiveness analysis (CEA) standards and can be equitable per distributional CEA (DCEA) standards,…
Learn MoreGene Therapy Not Cost-Effective for Sickle Cell by Conventional Measures
MONDAY, June 5, 2023 (HealthDay News) — For persons with sickle cell disease (SCD), gene therapy seems not to be cost-effective per conventional cost-effectiveness analysis (CEA) standards and can be equitable per distributional CEA (DCEA) standards,…
Learn MoreSickle Cell Gene Therapy Can Cure, But Costs Almost $3 Million. Who Will Pay?
WEDNESDAY, May 31, 2023 (HealthDay News) — An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether insurance companies will balk at the cost and deny coverage.On the surface, the gene ther…
Learn MoreSickle Cell Gene Therapy Can Cure, But Costs Almost $3 Million. Who Will Pay?
WEDNESDAY, May 31, 2023 (HealthDay News) — An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether insurance companies will balk at the cost and deny coverage.On the surface, the gene ther…
Learn MoreBenefits of Valoctocogene Roxaparvovec Persist in Hemophilia A
FRIDAY, March 3, 2023 (HealthDay News) — For patients with hemophilia A, factor VIII activity and bleeding reduction persist at two years after gene transfer with valoctocogene roxaparvovec, which delivers a B-domain-deleted factor VIII coding sequen…
Learn MoreGene Therapy Beneficial for Patients With Hemophilia B
FRIDAY, March 3, 2023 (HealthDay News) — For patients with hemophilia B, one infusion of adeno-associated virus 5 (AAV5) vector expressing the Padua factor IX variant (etranacogene dezaparvovec) is noninferior and superior to prophylaxis with factor …
Learn MoreUn nuevo avance podría acelerar la investigación sobre la terapia genética
JUEVES, 26 de enero de 2023 (HealthDay News) — Los “dedos de zinc” podrían sonar como el nombre de la peor barra de chocolate del mundo, pero estas proteínas humanas quizá resulten clave para tratar a las enfermedades complejas de origen genético.Un …
Learn More